Painchek Ltd (PCK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Painchek Ltd (PCK) has a cash flow conversion efficiency ratio of 1.892x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.11 Million ≈ $-1.49 Million USD) by net assets (AU$-1.11 Million ≈ $-787.47K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Painchek Ltd (PCK) balance sheet quality index to measure how much of total assets are equity-financed.
Painchek Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Painchek Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how aggressively does Painchek Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Painchek Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Painchek Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lachlan Star Ltd
AU:LSA
|
-0.026x |
|
Airo Lam limited
NSE:AIROLAM
|
0.083x |
|
Office Properties Income Trust
NASDAQ:OPI
|
0.030x |
|
Kingsmen C.M.T.I. Public Company Limited
BK:K
|
0.102x |
|
MMS Ventures Bhd
KLSE:0113
|
-0.026x |
|
CONSENSUS AS.MGM.B SK 5-
F:5XI
|
-0.055x |
|
Eratex Djaja Tbk
JK:ERTX
|
0.189x |
|
Mcphersons Ltd
AU:MCP
|
0.083x |
Annual Cash Flow Conversion Efficiency for Painchek Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Painchek Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Painchek Ltd (PCK) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-1.11 Million ≈ $-787.47K |
AU$-6.75 Million ≈ $-4.78 Million |
6.068x | +209.86% |
| 2024-06-30 | AU$1.29 Million ≈ $913.02K |
AU$-7.13 Million ≈ $-5.04 Million |
-5.524x | +41.63% |
| 2023-06-30 | AU$668.13K ≈ $472.75K |
AU$-6.32 Million ≈ $-4.47 Million |
-9.463x | -552.31% |
| 2022-06-30 | AU$4.82 Million ≈ $3.41 Million |
AU$-7.00 Million ≈ $-4.95 Million |
-1.451x | -190.23% |
| 2021-06-30 | AU$8.24 Million ≈ $5.83 Million |
AU$-4.12 Million ≈ $-2.92 Million |
-0.500x | -9.38% |
| 2020-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-1.89 Million ≈ $-1.33 Million |
-0.457x | +38.75% |
| 2019-06-30 | AU$4.12 Million ≈ $2.92 Million |
AU$-3.07 Million ≈ $-2.18 Million |
-0.746x | +17.40% |
| 2018-06-30 | AU$3.22 Million ≈ $2.28 Million |
AU$-2.91 Million ≈ $-2.06 Million |
-0.903x | -42.13% |
| 2017-06-30 | AU$2.48 Million ≈ $1.76 Million |
AU$-1.58 Million ≈ $-1.12 Million |
-0.636x | -123.79% |
| 2016-06-30 | AU$-914.86K ≈ $-647.32K |
AU$-2.44 Million ≈ $-1.73 Million |
2.671x | +19529.85% |
| 2011-06-30 | AU$164.24K ≈ $116.21K |
AU$-2.26K ≈ $-1.60K |
-0.014x | -- |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more